RhythmAnalytics vs Fetal EchoScan
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent rather than direct competitors, as they address different aspects of cardiac health using distinct diagnostic modalities. RhythmAnalytics focuses on the automated interpretation of cardiac arrhythmias from ECG data in general patient populations, providing clinical decision support for rhythm disorders. In contrast, Fetal EchoScan specializes in the prenatal detection of congenital heart defects through AI-powered ultrasound screening, assisting clinicians with structural anomalies in fetal hearts.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
RhythmAnalytics by Biofourmis is an AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. Fetal EchoScan by Brightheart is an FDA-cleared AI-powered ultrasound screening software that assists clinicians in the prenatal detection of congenital heart defects.
RhythmAnalytics analyzes single-lead ECG data, compatible with FDA-cleared ECG devices such as Holter, event recorders, and wearable sensors. Fetal EchoScan integrates with existing ultrasound workflows and analyzes ultrasound scan data for fetal heart assessments.
RhythmAnalytics is designed to support Cardiology, Emergency Medicine, and Internal Medicine. Fetal EchoScan is intended for use in Cardiology, Maternal-Fetal Medicine, and Radiology.
RhythmAnalytics is deployed as a cloud-based API, allowing for integration with other healthcare solutions. Fetal EchoScan is a cloud-based software-only device that integrates with existing ultrasound machines and reporting solutions (DICOM compatible), and offers a cart-side tablet display for real-time analysis.
RhythmAnalytics detects over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats. Fetal EchoScan focuses on the automated detection of congenital heart defects (CHDs) during prenatal ultrasound examinations.
RhythmAnalytics offers AI-based automated interpretation and analysis of ECG data for enhanced clinical decision support. Fetal EchoScan provides real-time guidance and feedback during ultrasound scans, ensures exam completeness, and aims to optimize workflow and reduce reading times for clinicians.